Skip to content
TrialScanner

NCT02636855

Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination

No phase registeredCompletedADAPYLead

Registry record

Lead sponsor
Adaptimmune
Conditions
Solid and Hematological Malignancies
Primary completion
Jun 28, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02636855 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.